Key facts
- This page summarizes Jeffrey L. Robins's Form 4 filing for Nu-Med Plus, Inc. (NUMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Dec 2023, 14:17.
Jeffrey L. Robins - 07 Nov 2023 Form 4 Insider Report for Nu-Med Plus, Inc. (NUMD)
- Reporting relationship
- Director
- Issuer ticker
- NUMD
- Reported as of
- 07 Nov 2023
- Net transaction value
- +$3,800
- Reporting owner signature
- /s/ Jeffrey L. Robins
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey L. Robins filed Form 4 for Nu-Med Plus, Inc. (NUMD) on 12 Dec 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$3,800.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUMD
transaction
Common Stock
Award
- Transaction value
- $3,800
- Shares
- +200,000
- Change %
- +4%
- Price
- $0.0190
- Shares after
- 5,200,000
- Date
- 07 Nov 2023
- Ownership
- Direct
NUMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,000,000
- Date
- 07 Nov 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.